Skip to main content
TRSO
OTC Technology

Transuite.Org Authorizes 1.1 Billion Shares, Discloses Delayed 10-K Filing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$0.1
Mkt Cap
$6.006M
52W Low
$0.055
52W High
$5.5
Market data snapshot near publication time

summarizeSummary

Transuite.Org Inc. amended its articles of incorporation to authorize 1.1 billion shares, significantly increasing potential dilution, and announced a delay in filing its annual 10-K report for fiscal year 2025.


check_boxKey Events

  • Massive Share Authorization

    Transuite.Org Inc. amended its articles of incorporation to authorize 1,100,000,000 shares, consisting of 1,000,000,000 common stock and 100,000,000 preferred stock.

  • Enables Future Financing

    The company stated this authorization enhances corporate flexibility for future financing alternatives, strategic transactions, acquisitions, and equity-based incentive arrangements.

  • Annual Report Filing Delayed

    The company announced a delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, attributing it to the scope of audit procedures and consolidation work for multiple subsidiaries.


auto_awesomeAnalysis

Transuite.Org Inc. has significantly increased its authorized capital stock to 1.1 billion shares, comprising 1 billion common and 100 million preferred shares. For a company with a market capitalization of approximately $6 million, this authorization represents an enormous potential for future dilution, signaling the company's intent to pursue substantial financing activities. While the company states this enhances corporate flexibility for growth initiatives and strategic transactions, existing shareholders face a considerable overhang from potential future share issuances. Additionally, the company disclosed a delay in filing its Annual Report on Form 10-K for fiscal year 2025, citing extensive audit and consolidation work for multiple subsidiaries. Delays in financial reporting are generally viewed negatively by the market, often indicating operational or accounting challenges and increasing investor uncertainty.

At the time of this filing, TRSO was trading at $0.10 on OTC in the Technology sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.05 to $5.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed TRSO - Latest Insights

TRSO
Apr 15, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
TRSO
Mar 13, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
TRSO
Mar 13, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
8
TRSO
Feb 27, 2026, 3:20 PM EST
Filing Type: PRE 14C
Importance Score:
9
TRSO
Feb 23, 2026, 2:44 PM EST
Filing Type: 8-K
Importance Score:
8
TRSO
Feb 12, 2026, 3:31 PM EST
Filing Type: 8-K
Importance Score:
7
TRSO
Jan 07, 2026, 12:10 PM EST
Filing Type: 8-K
Importance Score:
8